Emerging trends in modern pharmaceutics: translational drug delivery systems, data-driven formulation design, and advanced manufacturing paradigms

Abstract

The field of pharmaceutics plays a decisive role in determining whether newly developed therapies ultimately succeed in real-world patient use. The rapid expansion of advanced therapeutic modalities, including nucleic acid-based medicines, antibody-drug conjugates, and highly potent small-molecule drugs, has clearly exposed the limitations of conventional formulation approaches. As a result, there is a growing need for sophisticated drug delivery systems, intelligent formulation design strategies, and flexible manufacturing technologies capable of accommodating complex molecular entities. In parallel, regulatory authorities are actively encouraging innovation through initiatives that promote continuous manufacturing and enhanced real-time quality control. Against this background, the present review examines current trends in pharmaceutics, with particular focus on lipid nanoparticle-based delivery platforms, antibody drug conjugates, artificial intelligence-assisted formulation development, additive manufacturing, and continuous processing. Importantly, the discussion is grounded in recent clinical trial outcomes and patent activity, illustrating how modern pharmaceutics serves as a critical link between laboratory research and clinical application.